<

 
Data updated 2025-06-03 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date12165896.7 (espacenet)  (Federated)  (European Patent Register), 20090210
Patent/reg. no. and dateDK/EP 2505204, 20141224
Publication date20121003
Priority no. and dateUS 27741 P, 20080211, EP 08250703, 20080229
EP pub. no. and date EP 2505204 20121003
Effective date
Applicant/ownerFerring B.V., Polaris Avenue 144
2132 JX Hoofddorp, NL
Applicant ref. no.158723
InventorOLESEN, Tine Kold, 504 East 63 Street
Apt. 9P
New York, NY 10065, US,
Persson, Bo-Eric, Avenue de Beaulieu 8
1180 Rolle, CH,
Cantor, Per, Vilvordevej 6, 2920 Charlottenlund, DK,
van der Meulen, Egbert A, Angsgaten 7
S-24010 Dalby, SE,
Jensen, Jens-Christian, Slott, Solbaervaenget 38, 2880 Bagsværd, DK
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC ClassA61K 38/08 (2006.01) , A61K 38/09 (2006.01) , A61P 35/00 (2006.01) 
TitleFremgangsmåde til behandling af prostatakræft med GnRH-antagonisten degarelix
Int. application no.
Int. publication no.
Related patent (certificate)
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact